NASDAQ:TRDA | Insider Transactions — Page 6 | Entrada Therapeutics, Inc.

TRDA Insider Transactions — Page 6

517 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–517; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
5AM Partners V, LLCTenPercentOwner2021-11-02Purchase250,000.0$20.0
MPM BIOVENTURES 2018, L.P.TenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2018 GP LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2018 LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
GADICKE ANSBERTTenPercentOwner2021-11-02Purchase100,000.0$20.0
EVNIN LUKETenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2014, L.P.TenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2014 (B), L.P.TenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM Asset Management Investors BV2014 LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BIOVENTURES 2018 (B), L.P.TenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM ASSET MANAGEMENT INVESTORS BV2018 LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2014 LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
MPM BioVentures 2014 GP LLCTenPercentOwner2021-11-02Purchase100,000.0$20.0
Foley ToddDirector,TenPercentOwner2021-11-02Purchase100,000.0$20.0
Redmile Group, LLCTenPercentOwner2021-11-02Purchase1,000,000.0$20.0
Green JeremyTenPercentOwner2021-11-02Purchase1,000,000.0$20.0
Redmile Biopharma Investments III, L.P.TenPercentOwner2021-11-02Purchase1,000,000.0$20.0